Abstract
Retinal angiogenesis is a central feature of the leading causes of blindness. Current treatments for these conditions are of limited efficacy and cause significant adverse effects. In this study, we evaluated the angiostatic effect of gene transfer of the soluble VEGF receptor sFlt-1 in a mouse model of ischaemia-induced retinal neovascularisation using adenovirus and adeno-associated virus (AAV) vectors. We induced proliferative retinopathy in mice by exposure to 75% oxygen from postnatal day 7 (p7) to p12 and injected intravitreally recombinant viral vectors expressing the reporter green fluorescent protein (GFP) or vectors expressing the VEGF inhibitor sFlt-1. Efficient adenovirus-mediated GFP expression was evident in cells of the corneal endothelium and iris pigment epithelium. AAV-mediated GFP expression was evident in ganglion cells and cells of the inner nuclear layer of the retina. Vector-mediated sFlt-1 expression was confirmed by ELISA of pooled homogenised whole eyes. Injection of either vector expressing sFlt-1 resulted in a reduction in the number of neovascular endothelial cells by 56% and 52% for adenovirus and AAV vectors, respectively (P < 0.05). Local gene transfer of sFlt-1 consistently inhibits experimental retinal neovascularisation by approximately 50% and offers a powerful novel approach to the clinical management of retinal neovascular disorders.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Steinkuller P.G. et al. Childhood blindness J Aapos 1999 3: 26 26
Rahmani B. et al. The cause-specific prevalence of visual impairment in an urban population. The Baltimore Eye Survey Ophthalmology 1996 103: 1721 1721
Bressler N.M., Bressler S.B. . Preventative ophthalmology. Age-related macular degeneration Ophthalmology 1995 102: 1206 1206
Bressler N.M., Bressler S.B. . Preventative ophthalmology. Age-related macular degeneration
Bressler N.M., Bressler S.B. . Preventative ophthalmology. Age-related macular degeneration
Laser photocoagulation of subfoveal recurrent neovascular lesions in age-related macular degeneration. Results of a randomized clinical trial. Macular Photocoagulation Study Group, Arch Ophthalmol 1991; 109: 1232–1241 Cell 1996 86: 353 353
Aiello L.P. . Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies Ophthalmic Res 1997 29: 354 354
Ozaki H. et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization Am J Pathol 2000 156: 697 697
Pierce E.A. et al. Vascular endothelial growth factor/vascular permeability factor expression in a mouse model of retinal neovascularization Proc Natl Acad Sci USA 1995 92: 905 905
Shima D.T. et al. Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis Invest Ophthalmol Vis Sci 1996 37: 1334 1334
Mousa S.A., Lorelli W., Campochiaro P.A. . Role of hypoxia and extracellular matrix-integrin binding in the modulation of angiogenic growth factors secretion by retinal pigmented epithelial cells J Cell Biochem 1999 74: 135 135
Yi X., Mai L.C., Uyama M., Yew D.T. . Time-course expression of vascular endothelial growth factor as related to the development of the retinochoroidal vasculature in rats Exp Brain Res 1998 118: 155 155
Shweiki D., Itin A., Soffer D., Keshet E. . Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis Nature 1992 359: 843 843
Chen Y.S. et al. Localisation of vascular endothelial growth factor and its receptors to cells of vascular and avascular epiretinal membranes Br J Ophthalmol 1997 81: 919 919
Miller J.W. et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model Am J Pathol 1994 145: 574 574
Adamis A.P. et al. Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy Am J Ophthalmol 1994 118: 445 445
Aiello L.P. et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 1994 331: 1480 1480
Boulton M. et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management Br J Ophthalmol 1997 81: 228 228
Stone J. et al. Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity Invest Ophthalmol Vis Sci 1996 37: 290 290
Tolentino M.J. et al. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate Arch Ophthalmol 1996 114: 964 964
Okamoto N. et al. Transgenic mice with increased expression of vascular endothelial growth factor in the retina: a new model of intraretinal and subretinal neovascularization Am J Pathol 1997 151: 281 281
Robinson G.S. et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy Proc Natl Acad Sci USA 1996 93: 4851 4851
Adamis A.P. et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate Arch Ophthalmol 1996 114: 66 66
Kendall R.L., Thomas K.A. . Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor Proc Natl Acad Sci USA 1993 90: 10705 10705
Aiello L.P. et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins Proc Natl Acad Sci USA 1995 92: 10457 10457
Goldman C.K. et al. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate Proc Natl Acad Sci USA 1998 95: 8795 8795
Kong H.L. et al. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding a secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor Hum Gene Ther 1998 9: 823 823
Shiose S. et al. Gene transfer of a soluble receptor of VEGF inhibits the growth of experimental eyelid malignant melanoma Invest Ophthalmol Vis Sci 2000 41: 2395 2395
Kendall R.L., Wang G., Thomas K.A. . Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR Biochem Biophys Res Commun 1996 226: 324 324
Mordenti J. et al. Comparisons of the intraocular tissue distribution, pharmacokinetics, and safety of 125I-labeled full-length and Fab antibodies in rhesus monkeys following intravitreal administration Toxicol Pathol 1999 27: 536 536
Guembel H.O. et al. Complications after implantation of intraocular devices in patients with cytomegalovirus retinitis Graefes Arch Clin Exp Ophthalmol 1999 237: 824 824
Ali R.R. et al. Adeno-associated virus gene transfer to mouse retina Hum Gene Ther 1998 9: 81 81
Takayama K. et al. Suppression of tumor angiogenesis and growth by gene transfer of a soluble form of vascular endothelial growth factor receptor into a remote organ Cancer Res 2000 60: 2169 2169
Smith L.E. et al. Oxygen-induced retinopathy in the mouse Invest Ophthalmol Vis Sci 1994 35: 101 101
Reichel M.B. et al. Immune responses limit adenovirally mediated gene expression in the adult mouse eye Gene Therapy 1998 5: 1038 1038
Hoffman L.M., Maguire A.M., Bennett J. . Cell-mediated immune response and stability of intraocular transgene expression after adenovirus-mediated delivery Invest Ophthalmol Vis Sci 1997 38: 2224 2224
Cayouette M., Gravel C. . Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse Hum Gene Ther 1997 8: 423 423
Di Polo A. et al. Prolonged delivery of brain-derived neurotrophic factor by adenovirus-infected Muller cells temporarily rescues injured retinal ganglion cells Proc Natl Acad Sci USA 1998 95: 3978 3978
Sakamoto T. et al. Retinal functional change caused by adenoviral vector-mediated transfection of LacZ gene Hum Gene Ther 1998 9: 789 789
Fukuhara M., Suzuki A., Fukuda Y., Kosaka J. . Adenovirus vector-mediated gene transfer into rat retinal neurons and Muller cells in vitro and in vivo (published erratum appears in Neurosci Lett 1998; 243: 157) Neurosci Lett 1998 242: 93 93
Sakamoto T. et al. A vitrectomy improves the transfection efficiency of adenoviral vector-mediated gene transfer to Muller cells Gene Therapy 1998 5: 1088 1088
Alon T. . Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity Nat Med 1995 1: 1024 1024
Connolly S.E., Hores T.A., Smith L.E., D'Amore P.A. . Characterization of vascular development in the mouse retina Microvasc Res 1988 36: 275 275
Kolch W., Martiny-Baron G., Kieser A., Marme D. . Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis Breast Cancer Res Treat 1995 36: 139 139
Vitale S. et al. Clinically significant macular edema in type I diabetes. Incidence and risk factors Ophthalmology 1995 102: 1170 1170
Rothova A., Suttorp-van Schulten M.S., Frits Treffers W., Kijlstra A. . Causes and frequency of blindness in patients with intraocular inflammatory disease Br J Ophthalmol 1996 80: 332 332
Irvine A.R. et al. Macular edema after cataract extraction Ann Ophthalmol 1971 3: 1234 1234
Xiao X., Xiao W., Li J., Samulski R.J. . A novel 165-base-pair terminal repeat sequence is the sole cis requirement for the adeno-associated virus life cycle J Virol 1997 71: 941 941
Zhang X. et al. High-titer recombinant adeno-associated virus production from replicating amplicons and herpes vectors deleted for glycoprotein H Hum Gene Ther 1999 10: 2527 2527
Conway J.E. et al. High-titer recombinant adeno-associated virus production utilizing a recombinant herpes simplex virus type I vector expressing AAV-2 Rep and Cap Gene Therapy 1999 6: 986 986
Tobe T. et al. Evolution of neovascularization in mice with overexpression of vascular endothelial growth factor in photoreceptors Invest Ophthalmol Vis Sci 1998 39: 180 180
Acknowledgements
We wish to thank Keith Channon for provision of the Ad.GFP virus and M Feldman for help and advice. JWBB is a Wellcome Trust Research Training Fellow. AJT is a Wellcome Trust Senior Clinical Fellow. This work was also supported by Diabetes UK.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bainbridge, J., Mistry, A., De Alwis, M. et al. Inhibition of retinal neovascularisation by gene transfer of soluble VEGF receptor sFlt-1. Gene Ther 9, 320–326 (2002). https://doi.org/10.1038/sj.gt.3301680
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301680
Keywords
This article is cited by
-
AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies
BioDrugs (2024)
-
Updates on Gene Therapy for Diabetic Retinopathy
Current Diabetes Reports (2020)
-
Adenoviral vector encoding soluble Flt-1 engineered human endometrial mesenchymal stem cells effectively regress endometriotic lesions in NOD/SCID mice
Gene Therapy (2016)
-
Long-term efficacy of ciliary muscle gene transfer of three sFlt-1 variants in a rat model of laser-induced choroidal neovascularization
Gene Therapy (2013)
-
Gene transfer for ocular neovascularization and macular edema
Gene Therapy (2012)